Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -233,351 | -153,472 | -69,461 | -63,299 | N/A |
| Depreciation Amortization | 7,127 | 4,720 | 2,307 | 2,196 | N/A |
| Income taxes - deferred | 835 | 1,407 | 2,128 | N/A | N/A |
| Accounts receivable | -581 | -423 | -320 | -465 | N/A |
| Other Working Capital | 13,714 | 28,530 | -8,107 | -3,389 | N/A |
| Other Operating Activity | 31,946 | 20,927 | 8,052 | 11,644 | 0 |
| Operating Cash Flow | $-180,310 | $-98,311 | $-65,401 | $-53,313 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,146 | -15,658 | -6,394 | -8,785 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -562 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 122 | 0 |
| Investing Cash Flow | $-24,146 | $-15,658 | $-6,394 | $-8,663 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -608 | -271 | -137 | -67 | N/A |
| Common Stock Issued | 619 | 2 | 1 | 300,743 | N/A |
| Other Financing Activity | 0 | -143 | -72 | -872 | 0 |
| Financing Cash Flow | $11 | $-412 | $-208 | $299,804 | $N/A |
| Exchange Rate Effect | 131 | -4,906 | 11 | -3,753 | N/A |
| Beginning Cash Position | 559,227 | 559,227 | 559,227 | 325,152 | N/A |
| End Cash Position | 354,913 | 439,940 | 487,235 | 559,227 | N/A |
| Net Cash Flow | $-204,314 | $-119,287 | $-71,992 | $234,075 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -180,310 | -98,311 | -65,401 | -53,313 | N/A |
| Capital Expenditure | -24,663 | -15,658 | -6,394 | -8,785 | N/A |
| Free Cash Flow | -204,973 | -113,969 | -71,795 | -62,098 | 0 |